- RecruitingPHASE1
A Study to Evaluate the Safety and Tolerability of ALN-APP in Patients With EOAD
This study is looking at a new medicine called ALN-APP for people with early-onset Alzheimer's disease. Researchers want to see if it's safe and how it works. They will give it as a single dose or over several months to learn more.
For: Early-Onset Alzheimer DiseaseUnited States · Canada · Netherlands - RecruitingPHASE2
A Phase 2 Trial of ALN-APP in Patients With Cerebral Amyloid Angiopathy
This study is looking at a new medicine called ALN-APP for a condition called Cerebral Amyloid Angiopathy (CAA). It aims to see how well ALN-APP works to slow down CAA and if it's safe. Participants will either receive the new medicine or a dummy treatment.
For: Cerebral Amyloid AngiopathyUnited States · Australia · Canada